Market Overview:
The global automated implantable cardioverter-defibrillator market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of cardiovascular diseases, technological advancements in implantable cardioverter-defibrillators, and rising geriatric population. Based on type, the subcutaneous implantable cardioverter-defibrillators segment is expected to account for the largest share of the global automated implantable cardioverter-defibrillator market in 2018. This segment is also projected to grow at a CAGR of 7.8% from 2018 to 2030. The large share and high growth rate for this segment can be attributed to factors such as growing preference for minimally invasive procedures and increasing adoption of subcutaneous ICDs by physicians worldwide. Based on application, hospitals are expected to account for the largest share of the global automated implantable cardioverter-defibrillator market in 2018.
Product Definition:
An automated implantable cardioverter defibrillator (AICD) is a device that is implanted in the chest to monitor heart rhythms and deliver lifesaving shocks if needed.
The AICD is important because it can detect life-threatening heart rhythms and deliver a shock to restore normal rhythm. This can prevent sudden cardiac death, which occurs when the heart suddenly stops beating.
Subcutaneous Implantable Cardioverter-Defibrillators:
Subcutaneous implantable cardioverter-defibrillators (S-ICD) are used to treat bradycardia and tachycardia caused due to various reasons. It is also used for the treatment of ventricular fibrillation, which is a type of cardiac arrhythmia. The S-ICD has an ability to defibrillate the heart and restore normal sinus rhythm in patients suffering from life-threatening arrhythmias.
Transvenous Implantable Cardioverterâ€Defibrillator:
Transvenous implantable cardioverter defibrillator (ICD) is a medical device used to treat bradycardia and tachycardia. It is also used in the treatment of ventricular fibrillation, cardiac arrest, and asystole. The ICD monitors heart rate and provides an electric signal to the heart muscles to help them recover from their quiescent state into a sinus rhythm.
Application Insights:
The hospital application segment dominated the global automated implantable cardioverter defibrillator market in 2017. This is owing to a high number of patients suffering from cardiac arrest in hospitals across the world. According to data published by WHO, out of which 15% of people suffer from sudden cardiac arrest and die without any treatment, every year globally.
On the other hand, specialists clinics are expected to be fastest growing segment over the forecast period due to increasing adoption for arrhythmia management and catheter ablation procedures along with cost-effective products available in these clinics. Moreover, introduction of advanced software such as VE3S by Medtronic; firstly used worldwide for long QT syndrome treatment is also anticipated to boost growth during future years.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to high awareness levels regarding heart diseases, presence of sophisticated healthcare infrastructure and favorable reimbursement policies & regulatory reforms by government bodies. Moreover, increasing cases of cardiac arrests are also propelling the demand for AICD in this region. According to data published by American Heart Association (AHA), around 6 million people suffer from sudden cardiac arrest each year and about 130,000 people die due to it.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising geriatric population prone towards various chronic disorders including cardiovascular diseases (CVDs). In addition, improving healthcare facilities along with growing medical tourism will drive demand for automated implantable cardioverter defibrillator devices in this region during forecast period.
Growth Factors:
- Increasing incidence of cardiovascular diseases: The increasing incidence of cardiovascular diseases is the major growth driver for the automated implantable cardioverter defibrillator market. According to the World Health Organization, an estimated 17.5 million people died from CVDs in 2012, which accounted for 31% of all global deaths. This number is expected to increase to 23 million by 2030.
- Growing geriatric population: The growing geriatric population is another major growth driver for the automated implantable cardioverter defibrillator market as this population is more susceptible to CVDs than other age groups. By 2030, it is estimated that there will be 1 billion people over 60 years old worldwide, accounting for nearly 22% of the global population.
- Technological advancements: Technological advancements are driving the growth of the automated implantable cardioverter defibrillator market as they are resulting in improved device performance and increased patient safety. For instance, recent technological advances have led to development of smaller and more advanced devices that can be implanted without surgery or general anesthesia and can be automatically turned on and off based on a patient’s activity level or heart rate variability pattern respectively .
Scope Of The Report
Report Attributes
Report Details
Report Title
Automated Implantable Cardioverter Defibrillator Market Research Report
By Type
Subcutaneous Implantable Cardioverter-Defibrillators, Transvenous Implantable Cardioverter‐Defibrillator, Other
By Application
Hospital, Specialist Clinic, Other
By Companies
Medtronic, Abbott, Boston Scientific, ZOLL Medical, Nihon Kohden, LivaNova PLC, Imricor Medical Systems, MicroPort, St. Jude Medical, Biotronik, Sorin Group, Defibtech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
171
Number of Tables & Figures
120
Customization Available
Yes, the report can be customized as per your need.
Global Automated Implantable Cardioverter Defibrillator Market Report Segments:
The global Automated Implantable Cardioverter Defibrillator market is segmented on the basis of:
Types
Subcutaneous Implantable Cardioverter-Defibrillators, Transvenous Implantable Cardioverter‐Defibrillator, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Specialist Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Abbott
- Boston Scientific
- ZOLL Medical
- Nihon Kohden
- LivaNova PLC
- Imricor Medical Systems
- MicroPort
- St. Jude Medical
- Biotronik
- Sorin Group
- Defibtech
Highlights of The Automated Implantable Cardioverter Defibrillator Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Subcutaneous Implantable Cardioverter-Defibrillators
- Transvenous Implantable Cardioverter‐Defibrillator
- Other
- By Application:
- Hospital
- Specialist Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Automated Implantable Cardioverter Defibrillator Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
An automated implantable cardioverter defibrillator (AICD) is a medical device that helps to prevent sudden cardiac death. It is a small, wearable device that monitors heart rhythm and provides electrical shocks if needed to restore normal heart rhythm.
Some of the major companies in the automated implantable cardioverter defibrillator market are Medtronic, Abbott, Boston Scientific, ZOLL Medical, Nihon Kohden, LivaNova PLC, Imricor Medical Systems, MicroPort, St. Jude Medical, Biotronik, Sorin Group, Defibtech.
The automated implantable cardioverter defibrillator market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Automated Implantable Cardioverter Defibrillator Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Automated Implantable Cardioverter Defibrillator Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Automated Implantable Cardioverter Defibrillator Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Automated Implantable Cardioverter Defibrillator Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Automated Implantable Cardioverter Defibrillator Market Size & Forecast, 2018-2028
4.5.1 Automated Implantable Cardioverter Defibrillator Market Size and Y-o-Y Growth
4.5.2 Automated Implantable Cardioverter Defibrillator Market Absolute $ Opportunity
Chapter 5 Global Automated Implantable Cardioverter Defibrillator Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Automated Implantable Cardioverter Defibrillator Market Size Forecast by Type
5.2.1 Subcutaneous Implantable Cardioverter-Defibrillators
5.2.2 Transvenous Implantable Cardioverter‐Defibrillator
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Automated Implantable Cardioverter Defibrillator Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Automated Implantable Cardioverter Defibrillator Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Specialist Clinic
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Automated Implantable Cardioverter Defibrillator Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Automated Implantable Cardioverter Defibrillator Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Automated Implantable Cardioverter Defibrillator Analysis and Forecast
9.1 Introduction
9.2 North America Automated Implantable Cardioverter Defibrillator Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Automated Implantable Cardioverter Defibrillator Market Size Forecast by Type
9.6.1 Subcutaneous Implantable Cardioverter-Defibrillators
9.6.2 Transvenous Implantable Cardioverter‐Defibrillator
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Automated Implantable Cardioverter Defibrillator Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Specialist Clinic
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Automated Implantable Cardioverter Defibrillator Analysis and Forecast
10.1 Introduction
10.2 Europe Automated Implantable Cardioverter Defibrillator Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Automated Implantable Cardioverter Defibrillator Market Size Forecast by Type
10.6.1 Subcutaneous Implantable Cardioverter-Defibrillators
10.6.2 Transvenous Implantable Cardioverter‐Defibrillator
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Automated Implantable Cardioverter Defibrillator Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Specialist Clinic
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Automated Implantable Cardioverter Defibrillator Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Automated Implantable Cardioverter Defibrillator Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Automated Implantable Cardioverter Defibrillator Market Size Forecast by Type
11.6.1 Subcutaneous Implantable Cardioverter-Defibrillators
11.6.2 Transvenous Implantable Cardioverter‐Defibrillator
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Automated Implantable Cardioverter Defibrillator Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Specialist Clinic
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Automated Implantable Cardioverter Defibrillator Analysis and Forecast
12.1 Introduction
12.2 Latin America Automated Implantable Cardioverter Defibrillator Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Automated Implantable Cardioverter Defibrillator Market Size Forecast by Type
12.6.1 Subcutaneous Implantable Cardioverter-Defibrillators
12.6.2 Transvenous Implantable Cardioverter‐Defibrillator
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Automated Implantable Cardioverter Defibrillator Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Specialist Clinic
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Automated Implantable Cardioverter Defibrillator Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Automated Implantable Cardioverter Defibrillator Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Automated Implantable Cardioverter Defibrillator Market Size Forecast by Type
13.6.1 Subcutaneous Implantable Cardioverter-Defibrillators
13.6.2 Transvenous Implantable Cardioverter‐Defibrillator
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Automated Implantable Cardioverter Defibrillator Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Specialist Clinic
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Automated Implantable Cardioverter Defibrillator Market: Competitive Dashboard
14.2 Global Automated Implantable Cardioverter Defibrillator Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medtronic
14.3.2 Abbott
14.3.3 Boston Scientific
14.3.4 ZOLL Medical
14.3.5 Nihon Kohden
14.3.6 LivaNova PLC
14.3.7 Imricor Medical Systems
14.3.8 MicroPort
14.3.9 St. Jude Medical
14.3.10 Biotronik
14.3.11 Sorin Group
14.3.12 Defibtech
